Proteome Sciences PLC Result of AGM (7628Z)
17 Maio 2023 - 9:05AM
UK Regulatory
TIDMPRM
RNS Number : 7628Z
Proteome Sciences PLC
17 May 2023
17 May 2023
Proteome Sciences plc
("Proteome Sciences" or the "Company")
Result of Annual General Meeting (AGM)
The directors of Proteome Sciences are pleased to announce that
at the Company's AGM, held at 12.00 p.m. today, all resolutions
were duly passed.
Proteome Sciences plc
Dr. Mariola Soehngen, Chief Executive Officer Tel: +44 (0)20 7043 2116
Dr. Ian Pike, Chief Scientific Officer
Richard Dennis, Chief Commercial Officer
Abdelghani Omari, Chief Financial Officer
Allenby Capital Limited (Nominated Adviser & Broker)
John Depasquale / Jeremy Porter (Corporate Tel: +44 (0) 20 3328 5656
Finance)
Tony Quirke / Stefano Aquilino (Equity
Sales & Corporate Broking)
About Proteome Sciences plc. ( www.proteomics.com )
Proteome Sciences plc is a specialist provider of contract
proteomics services to enable drug discovery, development and
biomarker identification, and employs proprietary workflows for the
optimum analysis of tissues, cells and body fluids. SysQuant(R) and
TMT(R)MS2 are unbiased methods for identifying and contextualising
new targets and defining mechanisms of biological activity, while
analysis using Super-Depletion and TMTcalibrator(TM) provides
access to over 8,500 circulating plasma proteins for the discovery
of disease-related biomarkers. Targeted assay development using
mass spectrometry delivers high sensitivity, interference-free
biomarker analyses in situations where standard ELISA assays are
not available.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGARMBTMTABBLJ
(END) Dow Jones Newswires
May 17, 2023 08:05 ET (12:05 GMT)
Proteome Sciences (LSE:PRM)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Proteome Sciences (LSE:PRM)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024